欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号
DK/H/1783/003
药品名称
Karadronat
活性成分
risedronate sodium salt 35.0 mg
剂型
Film-coated tablet
上市许可持有人
Pharmathen S.A. 6, Dervenakion str. GR - 15351 Pallini Attikis Greece
参考成员国 - 产品名称
Denmark (DK)
互认成员国 - 产品名称
Italy (IT)
许可日期
2010/06/03
最近更新日期
2023/08/30
药物ATC编码
M05BA07 risedronic acid
申请类型
TypeLevel1:
Abridged
TypeLevel2:
Additional Strength/Form
TypeLevel3:
Generic Art 10.1 and 10.2 Dir 2001/83/EC
TypeLevel4:
Chemical Substance
TypeLevel5:
Prescription Only
附件文件下载
Final Labelling
|
Risedronate common_LAB_tracked 35 mg _ 1783
Date of last change:2024/09/06
Final PL
|
Risedronate common_PL_tracked 35 mg _ 1783
Date of last change:2024/09/06
Final SPC
|
Risedronate common_SPC_tracked 35 mg _ 1783
Date of last change:2024/09/06
市场状态
Positive
©2006-2025
Drugfuture
->
European Union HMA Authorisation of Medicines DataBase